Teleflex (NYSE:TFX) is scheduled to be issuing its quarterly earnings data before the market opens on Thursday, February 21st. Analysts expect the company to announce earnings of $2.78 per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.
Shares of NYSE:TFX opened at $281.58 on Thursday. The company has a current ratio of 2.26, a quick ratio of 1.51 and a debt-to-equity ratio of 0.83. Teleflex has a 1-year low of $226.02 and a 1-year high of $287.59. The company has a market cap of $12.67 billion, a price-to-earnings ratio of 33.52, a PEG ratio of 1.98 and a beta of 1.08.
In other news, insider Thomas E. Powell sold 5,324 shares of the business’s stock in a transaction on Thursday, December 27th. The shares were sold at an average price of $242.25, for a total value of $1,289,739.00. Following the transaction, the insider now owns 13,775 shares of the company’s stock, valued at $3,336,993.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Thomas E. Powell sold 5,200 shares of the business’s stock in a transaction on Friday, December 7th. The stock was sold at an average price of $259.41, for a total transaction of $1,348,932.00. Following the completion of the transaction, the insider now directly owns 13,651 shares in the company, valued at approximately $3,541,205.91. The disclosure for this sale can be found here. Insiders sold 21,148 shares of company stock worth $5,273,753 in the last three months. Insiders own 2.56% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Teleflex (TFX) Set to Announce Quarterly Earnings on Thursday” was originally published by Week Herald and is the property of of Week Herald. If you are viewing this story on another publication, it was copied illegally and republished in violation of US & international trademark and copyright legislation. The original version of this story can be viewed at https://weekherald.com/2019/02/14/teleflex-tfx-set-to-announce-quarterly-earnings-on-thursday.html.
Teleflex Company Profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.
Featured Article: How to calculate compound interest
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.